Year |
Citation |
Score |
2024 |
Warren G, Osborn M, Tsantoulas C, David-Pereira A, Cohn D, Duffy P, Ruston L, Johnson C, Bradshaw H, Kaczocha M, Ojima I, Yates A, O'Sullivan SE. Discovery and Preclinical Evaluation of a Novel Inhibitor of FABP5, ART26.12, Effective in Oxaliplatin-Induced Peripheral Neuropathy. The Journal of Pain. PMID 38232863 DOI: 10.1016/j.jpain.2024.01.335 |
0.318 |
|
2023 |
Glaser ST, Jayanetti K, Oubraim S, Hillowe A, Frank E, Jong J, Wang L, Wang H, Ojima I, Haj-Dahmane S, Kaczocha M. Fatty acid binding proteins are novel modulators of synaptic epoxyeicosatrienoic acid signaling in the brain. Scientific Reports. 13: 15234. PMID 37709856 DOI: 10.1038/s41598-023-42504-4 |
0.758 |
|
2023 |
Zhu C, Schutz L, Jayanetti K, Takemura K, Doswell F, Wang L, Ojima I, Kaczocha M. Truxillic acid monoamides as fatty acid binding protein 5 inhibitors. Bioorganic & Medicinal Chemistry. 94: 117464. PMID 37708641 DOI: 10.1016/j.bmc.2023.117464 |
0.437 |
|
2022 |
Fauzan M, Oubraim S, Yu M, Glaser ST, Kaczocha M, Haj-Dahmane S. Fatty Acid-Binding Protein 5 Modulates Brain Endocannabinoid Tone and Retrograde Signaling in the Striatum. Frontiers in Cellular Neuroscience. 16: 936939. PMID 35875351 DOI: 10.3389/fncel.2022.936939 |
0.727 |
|
2022 |
Bogdan DM, Studholme K, DiBua A, Gordon C, Kanjiya MP, Yu M, Puopolo M, Kaczocha M. FABP5 deletion in nociceptors augments endocannabinoid signaling and suppresses TRPV1 sensitization and inflammatory pain. Scientific Reports. 12: 9241. PMID 35655086 DOI: 10.1038/s41598-022-13284-0 |
0.34 |
|
2020 |
O'Sullivan SE, Kaczocha M. FABP5 as a novel molecular target in prostate cancer. Drug Discovery Today. PMID 32966866 DOI: 10.1016/J.Drudis.2020.09.018 |
0.444 |
|
2019 |
Carbonetti G, Wilpshaar T, Kroonen J, Studholme K, Converso C, d'Oelsnitz S, Kaczocha M. FABP5 coordinates lipid signaling that promotes prostate cancer metastasis. Scientific Reports. 9: 18944. PMID 31831821 DOI: 10.1038/S41598-019-55418-X |
0.417 |
|
2019 |
Carbonetti G, Converso C, Clement T, Wang C, Trotman L, Ojima I, Kaczocha M. Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth. The Prostate. PMID 31661167 DOI: 10.1002/Pros.23921 |
0.36 |
|
2019 |
Zhou Y, Elmes MW, Sweeney J, Joseph O, Che J, Hsu HC, Li H, Deutsch DG, Ojima I, Kaczocha M, Rizzo RC. Identification of Fatty Acid Binding Protein 5 Inhibitors Through Similarity-based Screening. Biochemistry. PMID 31539229 DOI: 10.1021/Acs.Biochem.9B00625 |
0.663 |
|
2019 |
Kim J, Bogdan DM, Elmes MW, Awwa M, Yan S, Che J, Lee G, Deutsch DG, Rizzo RC, Kaczocha M, Ojima I. Incarvillateine produces antinociceptive and motor suppressive effects via adenosine receptor activation. Plos One. 14: e0218619. PMID 31237895 DOI: 10.1371/Journal.Pone.0218619 |
0.683 |
|
2019 |
Elmes MW, Prentis LE, McGoldrick LL, Giuliano CJ, Sweeney JM, Joseph OM, Che J, Carbonetti GS, Studholme K, Deutsch DG, Rizzo RC, Glynn SE, Kaczocha M. FABP1 controls hepatic transport and biotransformation of Δ-THC. Scientific Reports. 9: 7588. PMID 31110286 DOI: 10.1038/S41598-019-44108-3 |
0.7 |
|
2018 |
Yan S, Elmes MW, Tong S, Hu K, Awwa M, Teng GYH, Jing Y, Freitag M, Gan Q, Clement T, Wei L, Sweeney JM, Joseph OM, Che J, Carbonetti GS, ... ... Kaczocha M, et al. SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins. European Journal of Medicinal Chemistry. 154: 233-252. PMID 29803996 DOI: 10.1016/J.Ejmech.2018.04.050 |
0.668 |
|
2018 |
Elmes MW, Volpe AD, d'Oelsnitz S, Sweeney JM, Kaczocha M. Lipocalin-Type Prostaglandin D Synthase Is a Novel Phytocannabinoid-Binding Protein. Lipids. PMID 29668081 DOI: 10.1002/Lipd.12035 |
0.409 |
|
2018 |
Hamilton J, Koumas C, Clavin BH, Marion M, Figueiredo A, Gonzalez S, O'Rourke JR, Deutsch D, Kaczocha M, Haj-Dahmane S, Thanos PK. Fatty acid-binding proteins 5 and 7 gene deletion increases sucrose consumption and diminishes forced swim immobility time. Behavioural Pharmacology. PMID 29570114 DOI: 10.1097/Fbp.0000000000000402 |
0.662 |
|
2018 |
Luk J, Lu Y, Ackermann A, Peng X, Bogdan D, Puopolo M, Komatsu DE, Tong S, Ojima I, Rebecchi MJ, Kaczocha M. Contribution of diacylglycerol lipase β to pain after surgery. Journal of Pain Research. 11: 473-482. PMID 29551907 DOI: 10.2147/Jpr.S157208 |
0.328 |
|
2018 |
Haj-Dahmane S, Shen RY, Elmes MW, Studholme K, Kanjiya MP, Bogdan D, Thanos PK, Miyauchi JT, Tsirka SE, Deutsch DG, Kaczocha M. Fatty-acid-binding protein 5 controls retrograde endocannabinoid signaling at central glutamate synapses. Proceedings of the National Academy of Sciences of the United States of America. PMID 29531087 DOI: 10.1073/Pnas.1721339115 |
0.666 |
|
2018 |
Hamilton J, Marion M, Figueiredo A, Clavin BH, Deutsch D, Kaczocha M, Haj-Dahmane S, Thanos PK. Fatty acid binding protein deletion prevents stress-induced preference for cocaine and dampens stress-induced corticosterone levels. Synapse (New York, N.Y.). PMID 29457656 DOI: 10.1002/Syn.22031 |
0.629 |
|
2018 |
Bogdan D, Falcone J, Kanjiya MP, Park SH, Carbonetti G, Studholme K, Gomez M, Lu Y, Elmes MW, Smietalo N, Yan S, Ojima I, Puopolo M, Kaczocha M. Fatty acid binding protein 5 controls microsomal prostaglandin E synthase 1 (mPGES-1) induction during inflammation. The Journal of Biological Chemistry. PMID 29440395 DOI: 10.1074/Jbc.Ra118.001593 |
0.404 |
|
2017 |
Figueiredo A, Hamilton J, Marion M, Blum K, Kaczocha M, Haj-Dahmane S, Deutsch D, Thanos PK. Pharmacological Inhibition of Brain Fatty Acid Binding Protein Reduces Ethanol Consumption in Mice. Journal of Reward Deficiency Syndrome and Addiction Science. 3: 21-27. PMID 29367955 |
0.63 |
|
2017 |
Hsu HC, Tong S, Zhou Y, Elmes MW, Yan S, Kaczocha M, Deutsch DG, Rizzo RC, Ojima I, Li H. The antinociceptive agent SBFI-26 binds to anandamide transporters FABP5 and FABP7 at two different sites. Biochemistry. PMID 28632393 DOI: 10.1021/Acs.Biochem.7B00194 |
0.686 |
|
2017 |
Peng X, Studholme K, Kanjiya MP, Luk J, Bogdan D, Elmes MW, Carbonetti G, Tong S, Gary Teng YH, Rizzo RC, Li H, Deutsch DG, Ojima I, Rebecchi MJ, Puopolo M, ... Kaczocha M, et al. Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms. Molecular Pain. 13: 1744806917697007. PMID 28326944 DOI: 10.1177/1744806917697007 |
0.676 |
|
2017 |
Chakraborty S, Elvezio V, Kaczocha M, Rebecchi M, Puopolo M. Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by norepinephrine in nociceptive neurons. The Journal of Physiology. PMID 28094445 DOI: 10.1113/Jp273455 |
0.328 |
|
2017 |
Figueiredo A, Hamilton J, Marion M, Blum K, Kaczocha M, Haj-Dahmane S, Deutsch D, Thanos PK. Pharmacological Inhibition of Brain Fatty Acid Binding Protein Reduces Ethanol Consumption in Mice Journal of Reward Deficiency Syndrome and Addiction Science. 3. DOI: 10.17756/JRDSAS.2017-037 |
0.66 |
|
2016 |
Martin GG, Chung S, Landrock D, Landrock KK, Dangott LJ, Peng X, Kaczocha M, Murphy EJ, Kier AB, Schroeder F. Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels. Lipids. PMID 27450559 DOI: 10.1007/S11745-016-4175-4 |
0.376 |
|
2016 |
Martin GG, Chung S, Landrock D, Landrock KK, Huang H, Dangott LJ, Peng X, Kaczocha M, Seeger DR, Murphy EJ, Golovko MY, Kier AB, Schroeder F. Fabp-1 gene ablation impacts brain endocannabinoid system in male mice. Journal of Neurochemistry. PMID 27167970 DOI: 10.1111/Jnc.13664 |
0.434 |
|
2016 |
Schroeder F, McIntosh AL, Martin GG, Huang H, Landrock D, Chung S, Landrock KK, Dangott LJ, Li S, Kaczocha M, Murphy EJ, Atshaves BP, Kier AB. Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias. Lipids. PMID 27117865 DOI: 10.1007/S11745-016-4155-8 |
0.391 |
|
2016 |
Thanos PK, Clavin BH, Hamilton J, O'Rourke JR, Maher T, Koumas C, Miao E, Lankop J, Elhage A, Haj-Dahmane S, Deutsch D, Kaczocha M. Examination of the Addictive and Behavioral Properties of Fatty Acid-Binding Protein Inhibitor SBFI26. Frontiers in Psychiatry. 7: 54. PMID 27092087 DOI: 10.3389/Fpsyt.2016.00054 |
0.69 |
|
2015 |
Kaczocha M, Glaser ST, Maher T, Clavin B, Hamilton J, O'Rourke J, Rebecchi M, Puopolo M, Owada Y, Thanos PK. Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms. Molecular Pain. 11: 52. PMID 26311517 DOI: 10.1186/S12990-015-0056-8 |
0.783 |
|
2015 |
Sirrs S, van Karnebeek CD, Peng X, Shyr C, Tarailo-Graovac M, Mandal R, Testa D, Dubin D, Carbonetti G, Glynn SE, Sayson B, Robinson WP, Han B, Wishart D, Ross CJ, ... ... Kaczocha M, et al. Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms. Orphanet Journal of Rare Diseases. 10: 38. PMID 25885783 DOI: 10.1186/S13023-015-0248-3 |
0.334 |
|
2015 |
Elmes MW, Kaczocha M, Berger WT, Leung K, Ralph BP, Wang L, Sweeney JM, Miyauchi JT, Tsirka SE, Ojima I, Deutsch DG. Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). The Journal of Biological Chemistry. 290: 8711-21. PMID 25666611 DOI: 10.1074/Jbc.M114.618447 |
0.733 |
|
2015 |
Kaczocha M, Glaser ST, Maher T, Clavin B, Hamilton J, O'Rourke J, Rebecchi M, Puopolo M, Owada Y, Thanos PK. Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms Molecular Pain. 11. DOI: 10.1186/s12990-015-0056-8 |
0.737 |
|
2014 |
Kaczocha M, Rebecchi MJ, Ralph BP, Teng YH, Berger WT, Galbavy W, Elmes MW, Glaser ST, Wang L, Rizzo RC, Deutsch DG, Ojima I. Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia. Plos One. 9: e94200. PMID 24705380 DOI: 10.1371/Journal.Pone.0094200 |
0.813 |
|
2014 |
Sanson B, Wang T, Sun J, Wang L, Kaczocha M, Ojima I, Deutsch D, Li H. Crystallographic study of FABP5 as an intracellular endocannabinoid transporter. Acta Crystallographica. Section D, Biological Crystallography. 70: 290-8. PMID 24531463 DOI: 10.1107/S1399004713026795 |
0.711 |
|
2013 |
Leung K, Elmes MW, Glaser ST, Deutsch DG, Kaczocha M. Role of FAAH-like anandamide transporter in anandamide inactivation. Plos One. 8: e79355. PMID 24223930 DOI: 10.1371/Journal.Pone.0079355 |
0.802 |
|
2013 |
Berger WT, Ralph BP, Kaczocha M, Sun J, Balius TE, Rizzo RC, Haj-Dahmane S, Ojima I, Deutsch DG. High throughput fluorescence displacement assay with NBD-stearate. Plos One. DOI: 10.1371/Journal.Pone.0050968.G008 |
0.569 |
|
2013 |
Berger WT, Ralph BP, Kaczocha M, Sun J, Balius TE, Rizzo RC, Haj-Dahmane S, Ojima I, Deutsch DG. Scheme demonstrating anandamide inactivation and FABP drug target. Plos One. DOI: 10.1371/Journal.Pone.0050968.G001 |
0.583 |
|
2012 |
Berger WT, Ralph BP, Kaczocha M, Sun J, Balius TE, Rizzo RC, Haj-Dahmane S, Ojima I, Deutsch DG. Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugs. Plos One. 7: e50968. PMID 23236415 DOI: 10.1371/Journal.Pone.0050968 |
0.721 |
|
2012 |
Kaczocha M, Lin Q, Nelson LD, McKinney MK, Cravatt BF, London E, Deutsch DG. Anandamide externally added to lipid vesicles containing trapped fatty acid amide hydrolase (FAAH) is readily hydrolyzed in a sterol-modulated fashion. Acs Chemical Neuroscience. 3: 364-8. PMID 22860204 DOI: 10.1021/Cn300001W |
0.662 |
|
2012 |
Kaczocha M, Vivieca S, Sun J, Glaser ST, Deutsch DG. Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors. The Journal of Biological Chemistry. 287: 3415-24. PMID 22170058 DOI: 10.1074/Jbc.M111.304907 |
0.813 |
|
2010 |
Glaser ST, Kaczocha M. Cyclooxygenase-2 mediates anandamide metabolism in the mouse brain. The Journal of Pharmacology and Experimental Therapeutics. 335: 380-8. PMID 20702753 DOI: 10.1124/Jpet.110.168831 |
0.73 |
|
2010 |
Kaczocha M, Glaser ST, Chae J, Brown DA, Deutsch DG. Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2. The Journal of Biological Chemistry. 285: 2796-806. PMID 19926788 DOI: 10.1074/Jbc.M109.058461 |
0.776 |
|
2009 |
Glaser ST, Kaczocha M. Temporal changes in mouse brain fatty acid amide hydrolase activity Neuroscience. 163: 594-600. PMID 19555737 DOI: 10.1016/J.Neuroscience.2009.06.043 |
0.73 |
|
2009 |
Kaczocha M, Glaser ST, Deutsch DG. Identification of intracellular carriers for the endocannabinoid anandamide. Proceedings of the National Academy of Sciences of the United States of America. 106: 6375-80. PMID 19307565 DOI: 10.1073/Pnas.0901515106 |
0.809 |
|
2006 |
Hermann A, Kaczocha M, Deutsch DG. 2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook. The Aaps Journal. 8: E409-12. PMID 16808043 DOI: 10.1007/Bf02854913 |
0.649 |
|
2006 |
Kaczocha M, Hermann A, Glaser ST, Bojesen IN, Deutsch DG. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase. The Journal of Biological Chemistry. 281: 9066-75. PMID 16461355 DOI: 10.1074/Jbc.M509721200 |
0.799 |
|
2005 |
Glaser ST, Kaczocha M, Deutsch DG. Anandamide transport: a critical review. Life Sciences. 77: 1584-604. PMID 15979096 DOI: 10.1016/J.Lfs.2005.05.007 |
0.812 |
|
2003 |
Glaser ST, Abumrad NA, Fatade F, Kaczocha M, Studholme KM, Deutsch DG. Evidence against the presence of an anandamide transporter. Proceedings of the National Academy of Sciences of the United States of America. 100: 4269-74. PMID 12655057 DOI: 10.1073/Pnas.0730816100 |
0.799 |
|
Show low-probability matches. |